Pillay J, Donovan L, Guitard S, Zakher B, Korownyk C, Gates M, Gates A, Vandermeer B, Bougatsos C, Chou R, Hartling L. 2021. Screening for gestational diabetes mellitus: A systematic review to update the 2014 U.S. Preventive Services Task Force Recommendation. Rockville, MD: Agency for Healthcare Research and Quality, 462 pp. (Evidence synthesis; no. 204; AHRQ publication; no. 21-05273-EF-1)
Annotation: This systematic review updates the 2012 evidence review used to inform the United States Preventive Services Task Force recommendations on the benefits and harms of screening for gestational diabetes mellitus. Since gestational diabetes mellitus is mostly asymptomatic, screening for it during pregnancy could identify women who could benefit from treatments to reduce the adverse consequences of this condition. Data sources included MEDLINE, Embase, and CINAHL between 2010 and May 2020; other sources included ClinicalTrials.gov, reference lists of primary studies and systematic reviews through June 2021. The results of this review showed that screening tests can identify women with gestational diabetes at or after 24 weeks of gestation and treatment is associated with improvement in various maternal and neonatal outcomes without serious harms.
Contact: U.S. Agency for Healthcare Research and Quality, 5600 Fishers Lane, Rockville, MD 20857, Telephone: (301) 427-1104 Secondary Telephone: (301) 427-1364 Web Site: http://www.ahrq.gov
Keywords: Diabetes mellitus, Evidence based medicine, Gestational diabetes, Literature reviews, Pregnancy, Pregnancy complications, Pregnancy outcomes, Pregnant women, Screening